ISSN 2639-9431
Vol. 1, Issue 3, 2018October 25, 2018 EDT
Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancer
Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancer
Articles in Vol. 1, Issue 3, 2018
Vol. 1, Issue 3, 2018
- Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancerMattaka KhongkowTzu-Yu LiuStacey BartlettWaleed M. HusseinReshma NevagiZhongfan JiaMichael J. MonteiroJames WellsUracha Rungsardthong RuktanonchaiMariusz SkwarczynskiIstvan Toth
- Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to DoxorubicinAdam FriedmanKenny YeAlicia Rodriguez-GabinJoshua NosanchukJoel FriedmanAlan AlfieriMahantesh NavantiAngelo LandriscinaJamie RosenDavid SchairerJoy MakdisiBrandon AdlerAimee KrauszHayley McDaid
- Specific molecular recognition as a strategy to delineate tumor margin using topically applied fluorescence embedded nanoparticlesWellington PhamShawn BartonBo LiMichael SiutaVaibhav A. JanveJessica SongClinton M. HoltTakumi TomonoMasami UkawaHironori KumagaiEtsuo TobitaKevin WilsonShinji Sakuma
- Plasma samples from mouse strains and humans demonstrate different in vitro susceptibilities to complement activationBarry W NeunGábor SzénásiJános SzebeniMarina Dobrovolskaia
Khongkow, Mattaka, Tzu-Yu Liu, Stacey Bartlett, Waleed M. Hussein, Reshma Nevagi, Zhongfan Jia, Michael J. Monteiro, et al. 2018. “Liposomal Formulation of Polyacrylate-Peptide Conjugate as a New Vaccine Candidate against Cervical Cancer.” Precision Nanomedicine 1 (3): 183–93. https://doi.org/10.33218/prnano1(3).181003.1.
